These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19580661)

  • 1. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement.
    Forlini C; Racine E
    BMC Med Ethics; 2009 Jul; 10():9. PubMed ID: 19580661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.
    Svetlov SI; Kobeissy FH; Gold MS
    J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults: The Clinical and Ethical Debates.
    Koren G; Korn L
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):100-102. PubMed ID: 33666399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.
    Linssen AM; Sambeth A; Vuurman EF; Riedel WJ
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):961-77. PubMed ID: 24423151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of methylphenidate among medical students: a systematic review.
    Finger G; Silva ER; Falavigna A
    Rev Assoc Med Bras (1992); 2013; 59(3):285-9. PubMed ID: 23680277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences.
    Bogle KE; Smith BH
    Curr Drug Abuse Rev; 2009 May; 2(2):157-76. PubMed ID: 19630746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness.
    Devilbiss DM; Berridge CW
    Biol Psychiatry; 2008 Oct; 64(7):626-35. PubMed ID: 18585681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of methylphenidate use by healthy medical students and doctors in South Africa.
    Beyer C; Staunton C; Moodley K
    BMC Med Ethics; 2014 Mar; 15():20. PubMed ID: 24592964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity.
    Jenson D; Yang K; Acevedo-Rodriguez A; Levine A; Broussard JI; Tang J; Dani JA
    Neuropharmacology; 2015 Mar; 90():23-32. PubMed ID: 25445492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes.
    Müller U; Suckling J; Zelaya F; Honey G; Faessel H; Williams SC; Routledge C; Brown J; Robbins TW; Bullmore ET
    Psychopharmacology (Berl); 2005 Aug; 180(4):624-33. PubMed ID: 15830222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive enhancement raises ethical concerns. Academics urge pre-emptive debate on neurotechnologies.
    Butcher J
    Lancet; 2003 Jul; 362(9378):132-3. PubMed ID: 12867135
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics and motives of college students who engage in nonmedical use of methylphenidate.
    Dupont RL; Coleman JJ; Bucher RH; Wilford BB
    Am J Addict; 2008; 17(3):167-71. PubMed ID: 18463991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic methylphenidate treatment on hippocampal neurovascular unit and memory performance in late adolescent rats.
    Coelho-Santos V; Cardoso FL; Magalhães A; Ferreira-Teixeira M; Leitão RA; Gomes C; Rito M; Barbosa M; Fontes-Ribeiro CA; Silva AP
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):195-210. PubMed ID: 30554860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enduring behavioral effects of early exposure to methylphenidate in rats.
    Carlezon WA; Mague SD; Andersen SL
    Biol Psychiatry; 2003 Dec; 54(12):1330-7. PubMed ID: 14675796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate-induced motor activity in rats: modulation by melatonin and vasopressin.
    Appenrodt E; Schwarzberg H
    Pharmacol Biochem Behav; 2003 Apr; 75(1):67-73. PubMed ID: 12759114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral response to methylphenidate challenge: influence of early life parental care.
    Engert V; Joober R; Meaney MJ; Hellhammer DH; Pruessner JC
    Dev Psychobiol; 2009 Jul; 51(5):408-16. PubMed ID: 19492313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury.
    Wagner AK; Kline AE; Ren D; Willard LA; Wenger MK; Zafonte RD; Dixon CE
    Behav Brain Res; 2007 Aug; 181(2):200-9. PubMed ID: 17517440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychopharmacological effects of methylphenidate].
    Ikeda K; Takamatsu Y; Hagino Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):121-3. PubMed ID: 19663262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology.
    Cooper NJ; Keage H; Hermens D; Williams LM; Debrota D; Clark CR; Gordon E
    J Integr Neurosci; 2005 Mar; 4(1):123-44. PubMed ID: 16035144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.